107 related articles for article (PubMed ID: 23235167)
1. [Conversion therapy of stage IV gastric cancer].
Tanizawa Y; Terashima M; Tokunaga M; Bando E; Kawamura T; Sugisawa N; Miki Y; Makuuchi R; Yamakawa Y; Kinugasa Y; Kanemoto H; Uesaka K; Yasui H
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2469-73. PubMed ID: 23235167
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
4. Significance of surgical treatment in multimodal therapy for stage IV highly advanced gastric cancer.
Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
Hepatogastroenterology; 2013; 60(122):377-81. PubMed ID: 22975650
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
6. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
7. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
Ajani JA; Mansfield PF; Janjan N; Morris J; Pisters PW; Lynch PM; Feig B; Myerson R; Nivers R; Cohen DS; Gunderson LL
J Clin Oncol; 2004 Jul; 22(14):2774-80. PubMed ID: 15254045
[TBL] [Abstract][Full Text] [Related]
9. [Treatment strategy for marginally resectable gastric cancer].
Nashimoto A; Yabusaki H; Nakagawa S; Matsuki A
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1246-51. PubMed ID: 21829060
[TBL] [Abstract][Full Text] [Related]
10. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of Conversion Gastrectomy Cases for Stage IV Gastric Cancer].
Ohnishi T; Kinami S; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Fujita H; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1799-1801. PubMed ID: 29394780
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of 56 patients with advanced gastric cancer treated with combination of intravenous and intra-arterial intensified neoadjuvant chemotherapy.
Li GL; Liu K; Bao Y; Cao JM; Xu J; Wang XL; Wu B; Li JS
Chin Med J (Engl); 2012 Mar; 125(5):780-5. PubMed ID: 22490574
[TBL] [Abstract][Full Text] [Related]
14. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
18. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
[TBL] [Abstract][Full Text] [Related]
20. Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
Rohatgi PR; Mansfield PF; Crane CH; Wu TT; Sunder PK; Ross WA; Morris JS; Pisters PW; Feig BW; Gunderson LL; Ajani JA
Cancer; 2006 Oct; 107(7):1475-82. PubMed ID: 16944539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
